These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 6168106

  • 1. [Importance of serum alpha-fetoprotein follow-up analysis in chronic liver diseases].
    Frysák Z, Hauftová D, Fingerová H.
    Vnitr Lek; 1981 Jun; 27(6):611-5. PubMed ID: 6168106
    [No Abstract] [Full Text] [Related]

  • 2. Serum alpha-fetoprotein in chronic liver disease.
    Weisz G, Udvardy M, Dalmi L, Kulcsár A.
    Acta Med Hung; 1983 Jun; 40(2-3):155-64. PubMed ID: 6199736
    [Abstract] [Full Text] [Related]

  • 3. [Alpha 1 fetoprotein-determiantion in patients with liver diseases].
    Lamerz R, Schmalhorst U, Grunst J.
    Z Gastroenterol Verh; 1976 Jun; (11):49-53. PubMed ID: 65863
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Follow-up analysis of persistent low positive serum alpha-fetoprotein (AFP)--report on 420 cases].
    Zhang BC.
    Zhonghua Zhong Liu Za Zhi; 1985 Jan; 7(1):26-8. PubMed ID: 2579782
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Determination of carcinoembryonic antigen and alpha fetoprotein in liver diseases].
    Hasik J, Klincewicz H, Majewski P, Witkowski J, Breborowicz J.
    Pol Tyg Lek; 1978 Jul 24; 33(30):1165-8. PubMed ID: 80796
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Stromal-predominant mesenchymal hamartoma of the liver with elevated serum alpha-fetoprotein level.
    Gunes D, Uysal KM, Cecen E, Cakmakci H, Ozer E, Akgur FM, Olgun N.
    Pediatr Hematol Oncol; 2008 Sep 24; 25(7):685-92. PubMed ID: 18850482
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Marked episodic elevations of alpha-fetoprotein without hepatocellular carcinoma in a patient with hepatitis B.
    Wong CB, Attar BM, Shimoda SS.
    Am J Gastroenterol; 1995 Jun 24; 90(6):1015-6. PubMed ID: 7539578
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Tumor markers in focal and diffuse liver diseases].
    Kasatkin IuN, Ametov AS, Mit'kov VV, Sevast'ianov SI, Zarudin VV.
    Med Radiol (Mosk); 1984 Apr 24; 29(4):39-43. PubMed ID: 6201693
    [Abstract] [Full Text] [Related]

  • 20. Use of serum PIVKA-II (DCP) determination for differentiation between benign and malignant liver diseases.
    Lamerz R, Runge M, Stieber P, Meissner E.
    Anticancer Res; 1999 Apr 24; 19(4A):2489-93. PubMed ID: 10470180
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.